Question 3 of 5
(demo test)

Product Demo for Clinical

A 48-year-old presents to his primary care provider for evaluation for shortness of breath. Following a negative laboratory evaluation, he underwent a CT of chest which demonstrated bilateral pulmonary disease concerning for metastatic disease. He proceeded with a CT guided biopsy of a pleural based lung lesion which demonstrate metastatic melanoma (BRAF wild-type). Additional staging work-up with an MRI of the brain demonstrated no evidence of intracranial disease. He is subsequently started on nivolumab therapy. Following initiation of nivolumab which side effects is correctly matched with their typically time of onset?

Heads up! You can use keyboard for test navigation: press for Next, for Previous, M for Mark/Unmark, P for Pause, R for Review, A,B,C,... or 1,2,3,... to select answer.